CL_2026-15.pdf
2026-07-17
INFORMATION ONLY Hizentra Updates
Customer Letter 2026-15 (PDF)
CL_2026-14.pdf
2026-07-17
INFORMATION ONLY Octaplasma Bag Colour Observation
Customer Letter 2026-14 (PDF)
CL_2026-13.pdf
2026-06-22
INFORMATION ONLY Rescind of Requisition – Request for Patient Blood Group Genotyping (F801221)For Hospitals Located Within Alberta Only
Customer Letter 2026-13 (PDF)
CL_2026-12.pdf
2026-06-15
INFORMATION ONLY Updates to Availability of Anti-IgA and RHD Genotyping Testing
Customer Letter 2026-12 (PDF)
CL_2026-11.pdf
2026-06-01
INFORMATION ONLY Wilate 500IU and 1000IU Updates
Customer Letter 2026-11 (PDF)
CL_2026-10.pdf
2026-05-11
INFORMATION ONLY Updated Diagnostic Services Antibody Investigation Request Form
Customer Letter 2026-10 (PDF) | F800185 (Legacy # F801802) CD0-1 Draft 1 EXAMPLE (PDF)
CL_2026-09
2026-05-11
INFORMATION ONLY Updated National Platelet Immunology Reference Laboratory (NPIRL) Requisition
Customer Letter 2026-09 (PDF) | F800052 CD1 2 Draft 1 EXAMPLE (PDF)
CL_2026-08.pdf
2026-04-27
INFORMATION ONLY Tamper Indication Tape Trial(Hospitals serviced by Canadian Blood Services Winnipeg Operations Only)
Customer Letter 2026-08 (PDF)
CL_2026-07.pdf
2026-04-27
INFORMATION ONLY Updated Request for Serological Investigation Requisition
Customer Letter 2026-07 (PDF) | F800086 Revision 2 Example (PDF)
CL_2026-06.pdf
2026-03-23
ACTION REQUIRED Updated Share Splits for Intravenous Immunoglobulins
Customer Letter 2026-06 (PDF)
CL_2026-05.pdf
2026-03-18
INFORMATION ONLY Panhematin – Over-Labelled Lot Number on Carton & Vial
Customer Letter 2026-05 (PDF)
CL_2026-04.pdf
2026-03-17
ACTION REQUIRED Complete Transition to 100% Digital Orders
Customer Letter 2026-04 (PDF)
CL_2026-03.pdf
2026-03-16
INFORMATION ONLY Canadian Blood Services Patient Test Results to the Ontario Laboratories Information System (OLIS)For Hospitals Located Within Ontario Only
Customer Letter 2026-03 (PDF)
CL_2026-02.pdf
2026-02-17
INFORMATION ONLY Updates to Manual Issue Vouchers
Customer Letter 2026-02 (PDF) | Attachment 1 (PDF) | Attachment 2 (PDF)
CL_2026-01.pdf
2026-01-27
INFORMATION ONLY Final Update: Discontinuation of Cryosupernatant Plasma (CSP)
Customer Letter 2026-01 (PDF)